Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study.
about
Lipid-lowering efficacy of atorvastatinLipid-lowering efficacy of rosuvastatinStatins impair glucose uptake in human cells.Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complicationsDo statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project.Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data.Effect of high-potency statins on HbA1c in patients with or without diabetes mellitus.Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol.Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathyStatins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes.Pharmacokinetic evaluation of atorvastatin and sitagliptin in combination for the treatment of type 2 diabetes.The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?Is statin-induced diabetes clinically relevant? A comprehensive review of the literature.An update on the benefits and risks of rosuvastatin therapy.Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications.Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis.Statins in the elderly: a patient-focused approach.Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism.Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.Effect of ezetimibe on insulin secretion in db/db diabetic mice.Do statins adversely affect the HbA1c of diabetic patients?Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia.Anti-hyperglycemic and anti-hyperlipidaemic effect of Arjunarisht in high-fat fed animals.Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis.Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trials.Atorvastatin inhibits CD68 expression in aortic root through a GRP78-involved pathway.Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million Patients
P2860
Q24187301-1256C093-CC85-4C08-B02A-4CE77C104CE7Q24187891-8E684989-F6F3-435D-A8A8-13AEA9A84A6AQ34419117-A2E9C081-A8DD-4B61-8FBA-B1F5E0337463Q35991064-5C1769A1-4680-457D-A884-5B5B974D252CQ36307061-181BD761-1E22-48C6-AC52-186B65E3A263Q36317577-6ED49A18-CE21-4C24-84F3-012712C0C463Q36705400-1E7F7206-280F-42DD-9B91-4C0E03F05B08Q37302061-1A804C5F-9734-4D0C-BF68-8E73ABF65C82Q37569809-A41F9A63-A31F-4668-9D67-09BD6E9926D0Q37729773-4C311064-C38C-469D-B609-B2EAD33DC6D8Q38010243-6CB1C1B3-AD87-4C43-AE55-73B146BEC7DCQ38103313-8493CC8D-AEEA-4F2B-8D65-0A1B0A9070E3Q38174285-63A7C89E-9A15-4669-BC71-D6706DA4B6DCQ38200826-1C918380-0985-4260-8538-D53B73BAAD3FQ38208727-67FA8C07-39E3-49A7-8156-EE8C21F525EEQ38222135-FF87F9FB-9F42-41CF-928B-ED9F044EACB5Q38253250-51F5C329-2790-4F3B-BE31-8308097F067EQ38261869-0E30E81A-6F65-4AD1-A4A8-A65E41B8A364Q38600327-09FAA5C3-92C4-41B1-9E2A-34FAEE77816CQ41494768-998E6CF3-EFB0-4053-9B9B-4F9B52EA455DQ41645854-6F0158BB-F55E-4DF1-9F2D-20EA974FF11CQ42269165-F52D2C9A-7378-41A0-AE60-60B7E230FDB5Q46813458-FA88E089-0120-4685-BC17-B36948AF53EEQ47241973-45E77002-FA19-46AB-9F01-E74403A92F15Q50858431-71C19A9D-8007-476A-8208-763D93ED14BFQ51339320-9F106DCE-EC8D-42D0-81D2-4822B1D88F3FQ51746469-01BBFAEE-F255-4138-A6F9-686D5E2B9A78Q58698213-22A084B6-22AD-4AA8-920B-B3C1179CF55C
P2860
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effects of rosuvastatin and at ...... 2 diabetes---the CORALL study.
@en
Effects of rosuvastatin and at ...... 2 diabetes---the CORALL study.
@nl
type
label
Effects of rosuvastatin and at ...... 2 diabetes---the CORALL study.
@en
Effects of rosuvastatin and at ...... 2 diabetes---the CORALL study.
@nl
prefLabel
Effects of rosuvastatin and at ...... 2 diabetes---the CORALL study.
@en
Effects of rosuvastatin and at ...... 2 diabetes---the CORALL study.
@nl
P2860
P1433
P1476
Effects of rosuvastatin and at ...... 2 diabetes---the CORALL study.
@en
P2093
B H R Wolffenbuttel
P2860
P304
P356
10.1111/J.1464-5491.2011.03553.X
P577
2012-05-01T00:00:00Z